9.1 Electrical Stimulation for Wound Healing
Key Takeaways
- Electrical stimulation delivers current through the wound to mimic the endogenous bioelectric "current of injury," promoting cell migration (electrotaxis), angiogenesis, perfusion, and antibacterial effects.
- High-voltage pulsed current is the most studied waveform: twin-peak monophasic pulses of very short duration at high peak voltage (commonly about 100 to 150 V) and roughly 100 pulses per second, applied for about 45 to 60 minutes, 5 to 7 days a week.
- Medicare's national coverage determination 270.1 covers electrical stimulation and electromagnetic therapy only for chronic stage 3 or 4 pressure ulcers, arterial ulcers, diabetic ulcers, and venous stasis ulcers after at least 30 days of appropriate standard wound care without measurable signs of healing.
- Under NCD 270.1, treatment must be furnished by a physician, physical therapist, or incident to a physician service, the wound must be evaluated at least monthly by the treating physician, coverage stops if no measurable healing occurs within any 30-day period or once the wound is fully epithelialized, and unsupervised use is not covered.
- Avoid electrical stimulation over malignancy, untreated osteomyelitis, the chest of patients with pacemakers or other implanted electronic devices, the carotid sinus and anterior neck, a pregnant abdomen, and wounds with residual metal ions from silver, iodine, or zinc products.
9.1 Electrical Stimulation for Wound Healing
Core Clinical Principle: Electrical stimulation (ES) is an adjunctive biophysical therapy for chronic wounds that have stalled despite good standard care. It is most useful when chosen for the right wound, delivered with correct parameters and electrode placement, and continued only while measurements show progress.
The CWSP outline lists electrical stimulation under biophysical technologies in Patient Management, and managing wounds with electrical stimulation is a listed task. Questions tend to focus on mechanisms, parameters, contraindications, and Medicare coverage rules.
The Bioelectric Basis of Healing
Intact epidermis maintains a transepithelial potential (the "skin battery") created by ion pumping, with the outer surface negative relative to deeper layers. When the skin is wounded, current leaks out through the moist wound, creating a lateral electric field known as the current of injury. That field guides cells toward the wound, a process called electrotaxis or galvanotaxis. A moist wound environment preserves this current, while desiccation weakens it.
Applied ES is thought to amplify these signals. Proposed effects include:
- Cell migration: In laboratory studies, keratinocytes and fibroblasts migrate toward the cathode (negative pole), while macrophages migrate toward the anode (positive pole).
- Proliferation and matrix: Increased fibroblast activity, collagen synthesis, and growth factor receptor expression.
- Perfusion: Increased local blood flow and tissue oxygen, plus reduced edema.
- Antibacterial effects: Reduced bacterial growth, especially near the cathode, and biofilm disruption in experimental models.
Types of Current
| Current | Description | Wound Use |
|---|---|---|
| Direct current (low-intensity) | Continuous one-directional flow, often in microamperes | Earliest wound studies; risk of skin irritation from electrochemical effects under electrodes |
| High-voltage pulsed current (HVPC) | Twin-peak monophasic pulses of very short duration (microseconds) at high peak voltage | Most studied wound waveform; very little net charge, so less risk of electrochemical burns |
| Biphasic pulsed current | Alternating pulses with balanced charge | Used in some wound and muscle stimulation protocols |
| Microcurrent and bioelectric dressings | Very low current from devices or dressings with embedded metal microcells | Limited but growing evidence |
A Typical HVPC Protocol
- Voltage: Commonly about 100 to 150 V peak, adjusted to a sub-motor level that the patient barely perceives (or the maximum tolerated in insensate tissue within protocol limits).
- Pulse rate: About 100 pulses per second.
- Duration and frequency: About 45 to 60 minutes per session, 5 to 7 days per week.
- Polarity: Many protocols start with the cathode (negative) over the wound during the inflammatory or infected phase, then switch to or alternate with the anode (positive) as the wound granulates; protocols vary because evidence on polarity is limited.
Electrode Setup
- Cleanse the wound and remove residues of silver, iodine, zinc, and petrolatum products, which can interfere with current flow or react at the electrode.
- Fill the wound with saline-moistened gauze and place the active electrode over it.
- Place the dispersive electrode on intact skin a short distance away (commonly at least 15 to 20 cm), usually proximal to the wound, so current passes through the wound bed.
- Check skin under electrodes before and after each session.
Evidence
- A meta-analysis of 15 studies by Gardner and colleagues (1999) found that chronic wounds treated with ES healed at about 22% per week versus about 9% per week with control treatment, roughly a 144% faster rate.
- Randomized trials support ES for pressure injuries, including in people with spinal cord injury, and for diabetic and venous ulcers, although many studies are small and use different protocols.
- The international pressure injury guideline suggests considering ES to promote healing of recalcitrant category/stage 2 and all category/stage 3 and 4 pressure injuries.
Medicare Coverage: NCD 270.1
| Requirement | Details |
|---|---|
| Covered wounds | Chronic stage 3 or stage 4 pressure ulcers, arterial ulcers, diabetic ulcers, and venous stasis ulcers |
| Not a first-line therapy | Covered only after appropriate standard wound therapy has been tried for at least 30 days with no measurable signs of healing |
| Standard care includes | Optimization of nutritional status, debridement to remove devitalized tissue, a clean and moist granulation bed with appropriate moist dressings, and treatment of any infection (good practice also requires offloading, compression, or revascularization as indicated) |
| Measurable signs of healing | Decrease in wound size (surface area or volume), decrease in exudate, and decrease in necrotic tissue |
| Continuation | Not covered if measurable signs of healing are absent within any 30-day period of treatment; discontinue when the wound bed is 100% epithelialized |
| Who provides it | Physician, physical therapist, or incident to a physician service; the treating physician must evaluate the wound at least monthly |
| Unsupervised use | Unsupervised use of ES or electromagnetic therapy for wounds is not covered |
Electromagnetic therapy (such as pulsed electromagnetic fields and pulsed shortwave diathermy) falls under the same coverage rules.
Contraindications and Precautions
| Avoid or Use With Great Caution | Reason |
|---|---|
| Malignancy in or near the wound | May stimulate tumor growth |
| Untreated osteomyelitis | Wound closure could trap infection; treat bone infection first |
| Electrodes over the chest in patients with a pacemaker, defibrillator, or other implanted electronic device | Device interference |
| Carotid sinus, anterior neck, and laryngeal muscles | Hypotension, laryngeal spasm |
| Abdomen, pelvis, or low back of a pregnant patient | Unknown fetal effects |
| Recent thrombosis or thrombophlebitis in the treatment area | Possible embolization with increased flow |
| Topical metal ions (silver, iodine, zinc) left in the wound | Ion transfer and skin reactions |
| Impaired sensation, active bleeding, and poor skin integrity under electrodes | Burn and bleeding risk; monitor closely |
Clinical Traps
Trap 1: Starting ES on Day 1
Medicare does not cover ES as an initial treatment. Document at least 30 days of appropriate standard care without measurable improvement first.
Trap 2: Leaving Silver Dressings in Place
Residual silver or iodine in the wound bed can react under the electrode. Remove metal-containing products and use saline-moistened gauze as the conducting medium.
A 71-year-old woman has a stage 4 sacral pressure injury. Her clinician wants to start electrical stimulation at her first wound clinic visit, before any standard wound therapy has been documented. Under Medicare national coverage determination 270.1, how will this be treated?
A physical therapist is preparing to apply high-voltage pulsed current to a chronic venous leg ulcer. Which situation requires the therapist to stop and change the plan before treatment?
A wound center reviews evidence before adding electrical stimulation. Which finding best summarizes the classic meta-analysis by Gardner and colleagues (1999)?